{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:13:13Z","timestamp":1789693993292,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s40272-016-0199-8","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T07:17:48Z","timestamp":1476947868000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Safety and Efficacy of Terlipressin in Pediatric Distributive Shock: A Retrospective Analysis in 20 Children"],"prefix":"10.1007","volume":"19","author":[{"given":"J\u00f6rg","family":"Michel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hofbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Spiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Renk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Neunhoeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"issue":"2","key":"199_CR1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.PCC.0000112521.93714.B8","volume":"5","author":"I Matok","year":"2004","unstructured":"Matok I, Leibovitch L, Vardi A, et al. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med. 2004;5(2):116\u20138.","journal-title":"Pediatr Crit Care Med."},{"issue":"3","key":"199_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00134-003-2114-3","volume":"30","author":"A Rodriguez-Nunez","year":"2004","unstructured":"Rodriguez-Nunez A, Fernandez-Sanmartin M, Martinon-Torres F, et al. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med. 2004;30(3):477\u201380. doi: 10.1007\/s00134-003-2114-3 .","journal-title":"Intensive Care Med."},{"issue":"1","key":"199_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.resuscitation.2005.06.016","volume":"68","author":"G Zeballos","year":"2006","unstructured":"Zeballos G, Lopez-Herce J, Fernandez C, et al. Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock. Resuscitation. 2006;68(1):151\u20133. doi: 10.1016\/j.resuscitation.2005.06.016 .","journal-title":"Resuscitation."},{"issue":"6","key":"199_CR4","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/PCC.0b013e3181fe304c","volume":"12","author":"L Filippi","year":"2011","unstructured":"Filippi L, Gozzini E, Daniotti M, et al. Rescue treatment with terlipressin in different scenarios of refractory hypotension in newborns and infants. Pediatr Crit Care Med. 2011;12(6):e237\u201341. doi: 10.1097\/PCC.0b013e3181fe304c .","journal-title":"Pediatr Crit Care Med."},{"issue":"7","key":"199_CR5","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s00134-008-1055-2","volume":"34","author":"N Jerath","year":"2008","unstructured":"Jerath N, Frndova H, McCrindle BW, et al. Clinical impact of vasopressin infusion on hemodynamics, liver and renal function in pediatric patients. Intensive Care Med. 2008;34(7):1274\u201380. doi: 10.1007\/s00134-008-1055-2 .","journal-title":"Intensive Care Med."},{"issue":"2","key":"199_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1442-200x.2005.02043.x","volume":"47","author":"S Masutani","year":"2005","unstructured":"Masutani S, Senzaki H, Ishido H, et al. Vasopressin in the treatment of vasodilatory shock in children. Pediatr Int. 2005;47(2):132\u20136. doi: 10.1111\/j.1442-200x.2005.02043.x .","journal-title":"Pediatr Int."},{"issue":"4","key":"199_CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.shk.0000158115.69704.11","volume":"23","author":"I Matok","year":"2005","unstructured":"Matok I, Vard A, Efrati O, et al. Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock. 2005;23(4):305\u201310.","journal-title":"Shock."},{"issue":"10","key":"199_CR8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1345\/aph.1P254","volume":"44","author":"A Rodriguez-Nunez","year":"2010","unstructured":"Rodriguez-Nunez A, Oulego-Erroz I, Gil-Anton J, et al. Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock. Ann Pharmacother. 2010;44(10):1545\u201353. doi: 10.1345\/aph.1P254 .","journal-title":"Ann Pharmacother."},{"issue":"4","key":"199_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s12098-011-0557-z","volume":"79","author":"A Agrawal","year":"2012","unstructured":"Agrawal A, Singh VK, Varma A, et al. Intravenous arginine vasopressin infusion in refractory vasodilatory shock: a clinical study. Indian J Pediatr. 2012;79(4):488\u201393. doi: 10.1007\/s12098-011-0557-z .","journal-title":"Indian J Pediatr."},{"issue":"9","key":"199_CR10","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/01.CCM.0000178182.37639.D6","volume":"33","author":"J Albanese","year":"2005","unstructured":"Albanese J, Leone M, Delmas A, et al. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med. 2005;33(9):1897\u2013902.","journal-title":"Crit Care Med."},{"issue":"1","key":"199_CR11","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1186\/cc3984","volume":"10","author":"A Rodriguez-Nunez","year":"2006","unstructured":"Rodriguez-Nunez A, Lopez-Herce J, Gil-Anton J, et al. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Crit Care. 2006;10(1):R20. doi: 10.1186\/cc3984 .","journal-title":"Crit Care."},{"issue":"3","key":"199_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00134-007-0971-x","volume":"34","author":"D Yildizdas","year":"2008","unstructured":"Yildizdas D, Yapicioglu H, Celik U, et al. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med. 2008;34(3):511\u20137. doi: 10.1007\/s00134-007-0971-x .","journal-title":"Intensive Care Med."},{"issue":"7","key":"199_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1164\/rccm.200902-0221OC","volume":"180","author":"K Choong","year":"2009","unstructured":"Choong K, Bohn D, Fraser DD, et al. Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. Am J Respir Crit Care Med. 2009;180(7):632\u20139. doi: 10.1164\/rccm.200902-0221OC .","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"199_CR14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.shk.0000136097.42048.bd","volume":"22","author":"M Leone","year":"2004","unstructured":"Leone M, Albanese J, Delmas A, et al. Terlipressin in catecholamine-resistant septic shock patients. Shock. 2004;22(4):314\u20139.","journal-title":"Shock."},{"issue":"4","key":"199_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00134-003-2094-3","volume":"30","author":"A Morelli","year":"2004","unstructured":"Morelli A, Rocco M, Conti G, et al. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med. 2004;30(4):597\u2013604. doi: 10.1007\/s00134-003-2094-3 .","journal-title":"Intensive Care Med."},{"issue":"9313","key":"199_CR16","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S0140-6736(02)08225-9","volume":"359","author":"A O\u2019Brien","year":"2002","unstructured":"O\u2019Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet. 2002;359(9313):1209\u201310. doi: 10.1016\/S0140-6736(02)08225-9 .","journal-title":"Lancet."},{"issue":"2","key":"199_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00134-002-1546-5","volume":"29","author":"M Westphal","year":"2003","unstructured":"Westphal M, Stubbe H, Sielenkamper AW, et al. Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med. 2003;29(2):301\u20138. doi: 10.1007\/s00134-002-1546-5 .","journal-title":"Intensive Care Med."},{"issue":"4","key":"199_CR18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13312-012-0046-0","volume":"49","author":"A Agrawal","year":"2012","unstructured":"Agrawal A, Singh VK, Varma A, et al. Therapeutic applications of vasopressin in pediatric patients. Indian Pediatr. 2012;49(4):297\u2013305.","journal-title":"Indian Pediatr."},{"issue":"2","key":"199_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/cc2945","volume":"9","author":"A Delmas","year":"2005","unstructured":"Delmas A, Leone M, Rousseau S, et al. Clinical review: vasopressin and terlipressin in septic shock patients. Crit Care. 2005;9(2):212\u201322. doi: 10.1186\/cc2945 .","journal-title":"Crit Care."},{"issue":"2","key":"199_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/cc4863","volume":"10","author":"M Leone","year":"2006","unstructured":"Leone M, Martin C. Rescue therapy in septic shock\u2014is terlipressin the last frontier? Crit Care. 2006;10(2):131. doi: 10.1186\/cc4863 .","journal-title":"Crit Care."},{"issue":"2","key":"199_CR21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bpa.2008.02.008","volume":"22","author":"M Leone","year":"2008","unstructured":"Leone M, Martin C. Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock. Best Pract Res Clin Anaesthesiol. 2008;22(2):323\u201333.","journal-title":"Best Pract Res Clin Anaesthesiol."},{"issue":"7\u20138","key":"199_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s10354-010-0853-7","volume":"161","author":"S Meyer","year":"2011","unstructured":"Meyer S, McGuire W, Gottschling S, et al. The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: review of the literature. Wien Med Wochenschr. 2011;161(7\u20138):192\u2013203. doi: 10.1007\/s10354-010-0853-7 .","journal-title":"Wien Med Wochenschr."},{"issue":"1","key":"199_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00134-011-2407-x","volume":"38","author":"A Polito","year":"2012","unstructured":"Polito A, Parisini E, Ricci Z, et al. Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. Intensive Care Med. 2012;38(1):9\u201319. doi: 10.1007\/s00134-011-2407-x .","journal-title":"Intensive Care Med."},{"key":"199_CR24","doi-asserted-by":"publisher","first-page":"CD009171","DOI":"10.1002\/14651858.CD009171.pub2","volume":"3","author":"B Shivanna","year":"2013","unstructured":"Shivanna B, Rios D, Rossano J, et al. Vasopressin and its analogues for the treatment of refractory hypotension in neonates. Cochrane Database Syst Rev. 2013;3:CD009171. doi: 10.1002\/14651858.CD009171.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"199_CR25","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00246-014-1059-3","volume":"36","author":"F Neunhoeffer","year":"2015","unstructured":"Neunhoeffer F, Renk H, Hofbeck M, et al. Safety, efficacy and response to a hydrocortisone rescue therapy protocol in children with refractory hypotension after cardiopulmonal bypass. Pediatr Cardiol. 2015;36(3):640\u20135. doi: 10.1007\/s00246-014-1059-3 .","journal-title":"Pediatr Cardiol."},{"issue":"7","key":"199_CR26","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/01.CCM.0000170943.23633.47","volume":"33","author":"AL Graciano","year":"2005","unstructured":"Graciano AL, Balko JA, Rahn DS, et al. The Pediatric Multiple Organ Dysfunction Score (P-MODS): development and validation of an objective scale to measure the severity of multiple organ dysfunction in critically ill children. Crit Care Med. 2005;33(7):1484\u201391.","journal-title":"Crit Care Med."},{"issue":"10","key":"199_CR27","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/sj.ki.5002231","volume":"71","author":"A Akcan-Arikan","year":"2007","unstructured":"Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71(10):1028\u201335. doi: 10.1038\/sj.ki.5002231 .","journal-title":"Kidney Int."},{"issue":"3","key":"199_CR28","first-page":"424","volume":"88","author":"ST Pierce","year":"1993","unstructured":"Pierce ST, Nickl N. Rhabdomyolysis associated with the use of intravenous vasopressin. Am J Gastroenterol. 1993;88(3):424\u20137.","journal-title":"Am J Gastroenterol."},{"issue":"2","key":"199_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000045496","volume":"83","author":"D Rolla","year":"1999","unstructured":"Rolla D, Cannella G, Ravetti JL. Toxic rhabdomyolysis induced by terlipressin infusion in a uraemic patient suffering from AA-type amyloidosis. Nephron. 1999;83(2):167\u20138. doi: 10.1159\/000045496 .","journal-title":"Nephron."},{"issue":"6","key":"199_CR30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/MAJ.0b013e3181ee9873","volume":"340","author":"V Zimmer","year":"2010","unstructured":"Zimmer V, Lammert F. Terlipressin-induced skin necrosis and rhabdomyolysis. Am J Med Sci. 2010;340(6):506. doi: 10.1097\/MAJ.0b013e3181ee9873 .","journal-title":"Am J Med Sci."},{"issue":"4","key":"199_CR31","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1017\/S1047951114000080","volume":"24","author":"LE Hernandez","year":"2014","unstructured":"Hernandez LE. Takotsubo cardiomyopathy: how much do we know of this syndrome in children and young adults? Cardiol Young. 2014;24(4):580\u201392. doi: 10.1017\/S1047951114000080 .","journal-title":"Cardiol Young."},{"issue":"5","key":"199_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11739-011-0534-6","volume":"6","author":"A Micoli Di","year":"2011","unstructured":"Di Micoli A, Buccione D, Degli Esposti D, et al. Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndrome. Intern Emerg Med. 2011;6(5):437\u201340. doi: 10.1007\/s11739-011-0534-6 .","journal-title":"Intern Emerg Med."},{"issue":"10","key":"199_CR33","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1346-8138.2012.01595.x","volume":"39","author":"YY Lu","year":"2012","unstructured":"Lu YY, Wei KC, Wu CS. Terlipressin-induced extensive skin necrosis: a case report and published work review. J Dermatol. 2012;39(10):866\u20138. doi: 10.1111\/j.1346-8138.2012.01595.x .","journal-title":"J Dermatol."},{"key":"199_CR34","doi-asserted-by":"publisher","first-page":"476","DOI":"10.12659\/AJCR.891084","volume":"15","author":"BD Ozel Coskun","year":"2014","unstructured":"Ozel Coskun BD, Karaman A, Gorkem H, et al. Terlipressin-induced ischemic skin necrosis: a rare association. Am J Case Rep. 2014;15:476\u20139. doi: 10.12659\/AJCR.891084 .","journal-title":"Am J Case Rep."},{"key":"199_CR35","doi-asserted-by":"publisher","unstructured":"Sundriyal D, Kumar N, Patnaik I, et al. Terlipressin induced ischaemia of skin. BMJ Case Rep. 2013. doi: 10.1136\/bcr-2013-010050 .","DOI":"10.1136\/bcr-2013-010050"},{"issue":"4","key":"199_CR36","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1365-2125.2007.02921.x","volume":"64","author":"F Donnellan","year":"2007","unstructured":"Donnellan F, Cullen G, Hegarty JE, et al. Ischaemic complications of Glypressin in liver disease: a case series. Br J Clin Pharmacol. 2007;64(4):550\u20132. doi: 10.1111\/j.1365-2125.2007.02921.x .","journal-title":"Br J Clin Pharmacol."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-016-0199-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-016-0199-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-016-0199-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:38:43Z","timestamp":1498354723000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-016-0199-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["199"],"URL":"https:\/\/doi.org\/10.1007\/s40272-016-0199-8","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,20]]}}}